Autor/es reacciones
Ramón Alemany
Head of the Cancer Virotherapy Group at the Bellvitge Biomedical Research Institute (IDIBELL).
EN
Head of the Cancer Virotherapy Group at the Bellvitge Biomedical Research Institute (IDIBELL).